Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis

  • Salem J
  • Allenbach Y
  • Vozy A
  • et al.
355Citations
Citations of this article
202Readers
Mendeley users who have this article in their library.

Abstract

Abatacept for Nivolumab-Induced Myocarditis Autoimmune myocarditis is a rare but often fatal complication of immune checkpoint inhibitor therapy for cancer. A case of glucocorticoid-refractory myoc...

Cite

CITATION STYLE

APA

Salem, J.-E., Allenbach, Y., Vozy, A., Brechot, N., Johnson, D. B., Moslehi, J. J., & Kerneis, M. (2019). Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis. New England Journal of Medicine, 380(24), 2377–2379. https://doi.org/10.1056/nejmc1901677

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free